Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches



Rating:

Share or cite this content

Citations should be made in the following way:
S. Zaytseva (Moscow, Russian Federation), O. Zaytseva (Moscow, Russian Federation), E. Lokshina (Moscow, Russian Federation), A. Tomilova (Moscow, Russian Federation), O. Voronina (Moscow, Russian Federation), O. Murtazaeva (Moscow, Russian Federation), . Mukhortykh (Moscow, Russian Federation), I. Tsymbal (Moscow, Russian Federation). Use of Omalizumab in children in real clinical practice.. 3918

Member's Comments

No comment yet.

Related content which might interest you: Use and misuse of clinical and evidence-based guidelines in clinical practice Source: Annual Congress 2009 - Physiotherapy for the respiratory patient: evidence-based guidelines Year: 2009 Analysis of two-year treatment with omalizumab patients with severe asthma in real clinical practice Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma Year: 2019 Efficacy and safety of omalizumab in real-life practice in India Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE Year: 2012 Omalizumab decreases medical resource utilisation in patients with severe allergic asthma in an Italian real-life setting Source: International Congress 2017 – Asthma management Year: 2017 Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Treatment of childhood asthma in Malaysia: adherence of general practice preferences to clinical practice guidelines Source: Eur Respir J 2002; 20: Suppl. 38, 332s Year: 2002 Omalizumab in practice: learning from experience Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives Year: 2007 New and future developments of therapy for asthma in children Source: Eur Respir Mon 2012; 56: 224-234 Year: 2012 Reduced healthcare resource utilization in asthma patients treated with omalizumab in the clinical practice in Spain Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Current diagnostic practice for occupational asthma in the UK. Patient versus physician Source: Eur Respir J 2004; 24: Suppl. 48, 367s Year: 2004 Italian real-life experience of omalizumab Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Evaluating response to omalizumab (anti-IgE) in clinical practice Source: Eur Respir J 2005; 26: Suppl. 49, 48s Year: 2005 Efficiency of different strategies of asthma control achievement in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Implementation of questionnaires in the management of asthma patients in clinical practice Source: Annual Congress 2013 –PG18 Assessing the health status and quality of life in asthma and COPD patients Year: 2013 Phenotypes related with clinical improvement of omalizumab-treated patients in routine clinical practice. FENOMA Study Source: International Congress 2017 – Techniques to treat asthma Year: 2017 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Considerations of a real life pragmatic clinical trial in adolescent asthma Source: Eur Respir J, 58 (3) 2100461; 10.1183/13993003.00461-2021 Year: 2021 Selecting patients in clinical practice Source: School Course 2012 - Practical Issues in Pulmonary Rehabilitation Year: 2012 Use and safety of histamine challenge testing in clinical practice Source: Eur Respir J 2002; 20: Suppl. 38, 409s Year: 2002